NH PHL Discipline B Chemistry Analytical Track 1 - food defense

学科B：化学 分析轨道1：食品防御 确保用于分析的食品和食品分析的实验室突击能力 与化学污染有关，国家公共卫生部门计划通过故意手段： 1.参加FDA要求的年度分流演习和/或监督活动，以支持 并保持准备状态。 2.如有可能，参加国家安全事件演习。 3.做好准备，对疑似或确认的故意行为做出快速反应 涉及人或动物性食品的污染事件。这包括确保分析师接受培训 并通过了能力练习，设备处于工作状态，试剂和 有补给可用。 4.在食品供应受到怀疑或可信威胁的情况下，参与相关检测 根据FDA的要求，怀疑是化学试剂 NH PHL保持随时准备并有能力检测蔬菜和 水果(新鲜和包装)；果汁(浓缩和稀释)；谷物和谷物产品；海鲜 和其他鱼类产品；牛奶和其他乳制品；婴儿配方奶粉；婴儿食品；瓶装水； 调味品；和酒精产品(啤酒、葡萄酒、苏格兰威士忌)。 NH PHL将参加并通过年度水平测试，参加LFFM面对面会议 和每月通话，保持国际标准化组织17025认证的CHE.0009等方法的秋季 在我们的认可下，维护完成工作所需的设施和人员 建议，并提供收集和分析的所有样本的详细季度摘要。这个 NH PHL将与FDA保持20.88年的有效协议。

Discipline B: Chemistry Analytical Track 1: Food Defense To ensure laboratory surge capacity in the analyses of foods and food products for analyses related to chemical contamination, through intentional means, the NH PHL plans to: 1. Participate in FDA-requested annual triage exercises, and/or surveillance activities to support and maintain readiness. 2. Participate in national security event exercises, as available. 3. Maintain preparedness to rapidly respond to a suspected or confirmed intentional contamination event involving human or animal food. This includes ensuring analysts are trained and have passed competency exercises, equipment is in working order, and reagents and supplies are available. 4. Participate in testing associated with suspected or credible threats to the food supply where a chemical agent is suspected, as requested by FDA The NH PHL maintains readiness and ability to detect chemical contamination in vegetables and fruits (fresh and packaged); juices (concentrate and diluted); grains and grain products; seafood and other fish products; milk and other dairy products; infant formula; baby foods; bottled water; condiments; and alcoholic products (beer, wine, scotch). NH PHL will participate and pass annual proficiency tests, attend the LFFM Face-to-Face meeting and monthly calls, maintain ISO 17025 accreditation of CHE.0009 and other methods that fall under our accreditation, maintain facilities and personnel necessary to complete the work proposed, and provide a detailed quarterly summary of all samples collected and analyzed. The NH PHL will maintain a valid 20.88 agreement with the FDA.